GLTO Stock Analysis: Buy, Sell, or Hold?
GLTO - Galecto, Inc. Common Stock
$28.69
-0.22 (-0.76%)
âŧ
5d:
-4.53%
30d:
+26.78%
90d:
+29.5%
WAIT
LOW Confidence
Analysis Updated: Mar 9, 2026 12:00 AM ET
Earnings: Mar 18, 2026
0d
Get Alerted When GLTO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GLTO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GLTO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GLTO is currently trading at $28.69, which is considered fair based on recent price action.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $27.10, while resistance sits at $33.99.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.00 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLTO is in a strong uptrend. Immediate support is located at $27.10, while resistance sits at $33.99.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.00 (+11.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
45/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading below Wall St target ($32.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$27.10
Resistance Level
$33.99
Current Trend
Strong Uptrend
Technical data as of
Mar 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.39
Wall Street Target
$32.00
(+11.5%)
Share & Embed Analysis
Last updated: August 15, 2026 1:44 PM ET
Data refreshes hourly during market hours. Next update: 2:44 PM
Data refreshes hourly during market hours. Next update: 2:44 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLTO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$376 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$431 | 33 SELL |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$559 | 32 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 52 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
